Panitumumab (Vectibix®) in Cutaneous Squamous Cell Carcinoma (SCC)

NCT01129154 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Squamous Cell

Interventions

DRUG: infusions of Panitumumab

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Collaborators

[object Object]
[object Object]